New approaches to cyclosporine monitoring raise further concerns about analytical techniques

Clinical Chemistry

Volumn 46, Issue 6, 2000, Pages 872-874

  Holt, David W ^a   Johnston, Atholl ^b   Kahan, Barry D ^c   Morris, Raymond G ^d   Oellerich, Michael ^e   Shaw, Leslie M ^f  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TEXAS   (United States)

^d QUEEN ELIZABETH HOSPITAL   (Australia)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; DRUG MONITORING; HUMAN; HUMAN CELL; LABORATORY TEST; PREDICTION; RADIOIMMUNOASSAY;

EID: 0034046768     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.6.872     Document Type: Article

References (11)

1. 1. Lindholm A, Kahan BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993;54:205-18.
2. 2. Johnston A, Sketris I, Marsden JT, Galustian CG, Fashola T, Taube D, et al. A limited sampling strategy for the measurement of cyclosporine AUC. Transplant Proc 1990;22:1345-6.
3. 3. Grevel J, Kahan BD. Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy. Clin Chem 1991;37:1905-8.
4. 4. Amante AJ, Kahan BD. Abbreviated area-under-the-curve strategy for monitoring cyclosporine microemulsion therapy in immediate posttransplant period. Clin Chem 1996;42:1294-6.
5. 5. Grant D, Kneteman N, Tchervenkov J, Roy A, Murphy G, Tan A, et al. Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: results of a prospective, randomized comparison of Neoral and Sandimmune for liver transplantation (NOF-8). Transplantation 1999;67:1133-7.
6. 6. Mahalati K, Belitsky P, Sketris I, West K, Panek R. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Transplantation 1999;68:55-62.
7. 7. Mahalati K, Lawen J, Kiberd B, Belitsky P. Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period? J Urol 2000;163:37-41.
8. 8. Steimer W, Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific? Clin Chem 1999;45:371-81.
9. 9. Schutz E, Svinarov D, Shipkova M, Niedmann P-D, Armstrong VW, Wieland E, Oellerich M. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC. Clin Chem 1998;44:2158-64.
10. 10. International Cyclosporin Proficiency Testing Scheme, 1999. http://www. asil.demon.co.uk.
11. 11. Holt DW, Jones K, Lee T, Stadler P, Johnston A. Quality assessment issues of new immunosuppressive drugs and experimental experience. Ther Drug Monit 1996;18:362-7.